Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126230451 | 12623045 | 1 | I | 20160725 | 20160804 | 20160804 | EXP | JP-FRESENIUS KABI-FK201605059 | FRESENIUS KABI | OSAWA G,YOSHIMATSU K,YOKOMIZO H,OTANI T,YANO Y,ITAGAKI H. A CASE OF MULTIPLE LUNG AND LIVER METASTASES FROM COLON CANCER TREATED WITH CLINICAL BENEFIT BY HEPATIC ARTERIAL INFUSION CHEMOTHERAPY PLUS CETUXIMAB MONO-THERAPY AFTER STANDARD CHEMOTHERAPY FAILURE. GAN-TO-KAGAKU-RYOHO 2010;37(12):2526-2528. | 61.00 | YR | F | Y | 0.00000 | 20160804 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126230451 | 12623045 | 1 | PS | FLUOROURACIL (Manufacturer unknown) | FLUOROURACIL | 1 | Unknown | U | UNKNOWN | 40278 | 1000 | MG/M**2 | |||||||
| 126230451 | 12623045 | 2 | SS | FLUOROURACIL (Manufacturer unknown) | FLUOROURACIL | 1 | U | UNKNOWN | 40278 | ||||||||||
| 126230451 | 12623045 | 3 | SS | FLUOROURACIL (Manufacturer unknown) | FLUOROURACIL | 1 | U | UNKNOWN | 40278 | ||||||||||
| 126230451 | 12623045 | 4 | SS | CETUXIMAB | CETUXIMAB | 1 | 0 | 250 | MG/M**2 | ||||||||||
| 126230451 | 12623045 | 5 | SS | CETUXIMAB | CETUXIMAB | 1 | 0 | 250 | MG/M**2 | ||||||||||
| 126230451 | 12623045 | 6 | SS | CETUXIMAB | CETUXIMAB | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126230451 | 12623045 | 1 | Colon cancer |
| 126230451 | 12623045 | 2 | Metastases to liver |
| 126230451 | 12623045 | 3 | Metastases to lung |
| 126230451 | 12623045 | 4 | Colon cancer |
| 126230451 | 12623045 | 5 | Metastases to liver |
| 126230451 | 12623045 | 6 | Metastases to lung |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126230451 | 12623045 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126230451 | 12623045 | Dermatitis acneiform |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126230451 | 12623045 | 1 | 200911 | 0 | ||
| 126230451 | 12623045 | 4 | 200805 | 0 | ||
| 126230451 | 12623045 | 5 | 200905 | 0 |